Barkin, PharmD, MBA, Robert L., United States

• Vol 4, No 3 (2008): May/June - Articles
  Oxymorphone and oxymorphone extended release: A pharmacotherapeutic review
  Abstract
• Vol 3, No 5 (2007): September/October - Editorial
  Tactics of the physician-controlled counter—detail and the imminent risk of not changing pharma’s detail relationship with physicians
  Abstract  PDF